Effects of Renin-Angiotensin Blockade and APOL1 on Kidney Function in Sickle Cell Disease

EJHaem. 2021 Aug;2(3):483-484. doi: 10.1002/jha2.259. Epub 2021 Jul 8.

Authors

Jin Han^{1

2}, Andrew Srisuwananukorn², Binal N Shah², Robert E Molokie^{2

3}, James P Lash⁴, Victor R Gordeuk², Santosh L Saraf²

Affiliations

¹ Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL.
² Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL.
³ Department of Medicine, Jesse Brown VA Medical Center, Chicago, IL.
⁴ Division of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago, IL.

No abstract available

Keywords: APOL1; Angiotensin converting enzyme inhibitors; Angiotensin receptor blockers; Sickle cell disease.

Grants and funding